Hatsukami Dorothy K, Luo Xianghua, Dick Laura, Kangkum Margarita, Allen Sharon S, Murphy Sharon E, Hecht Stephen S, Shields Peter G, al'Absi Mustafa
Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.
Department of Psychiatry, University of Minnesota, Minneapolis, MN, USA.
Addiction. 2017 Jan;112(1):156-167. doi: 10.1111/add.13603. Epub 2016 Nov 2.
To compare the use of alternative nicotine products, smoking behavior and tobacco biomarker exposure in smokers unwilling to quit who were assigned randomly to normal nicotine content (NNC) cigarettes or very low nicotine content (VLNC) cigarettes.
Randomized, parallel-arm 8-week study with assignment to VLNC (VLNC 1, n = 53) or NNC (NNC, n = 27) with access to non-cigarette combusted and non-combusted tobacco/nicotine products or to VLNC with access to only non-combusted products (VLNC2, n = 56).
Clinics in Minnesota, USA.
Smokers uninterested in quitting smoking with a mean [± standard deviation (SD)] age of 44 (± 14) years and smoking 16 (± seven) cigarettes/day; 51% female, 72% white.
During the experimental period, the measures taken included: rate of alternative products used, amount of and abstinence from combusted tobacco used and tobacco exposure biomarkers.
There were higher rates of non-combusted alternative tobacco/nicotine product use in both VLNC conditions versus the NNC condition [rate ratio (RR) = 2.18, 95% confidence interval (CI) = 1.94, 2.46 and RR = 1.64, 95% CI = 1.46, 1.85, respectively] and in VLNC1 versus VLNC2 condition (RR = 1.33, 95% CI = 1.23, 1.44), accompanied by reduced biomarkers of exposure primarily in VLNC2 condition compared to NNC condition (Ps < 0.05). Fewer combusted products were smoked at almost all visits (Ps ≤ 0.02) and there were higher rates of abstinence for both VLNC conditions compared with the NNC condition (VLNC1 versus NNC: RR = 9.96, 95% CI = 5.01, 19.81; VLNC2 versus NNC: RR = 11.23, 95% CI = 5.74, 21.97).
The offer of, and instructions to use, reduced nicotine content cigarettes during an 8-week period led to greater use of alternative tobacco/nicotine products compared with continued use of normal nicotine cigarettes and also reductions in smoking rates.
比较随机分配至正常尼古丁含量(NNC)香烟或极低尼古丁含量(VLNC)香烟的不愿戒烟吸烟者使用替代尼古丁产品的情况、吸烟行为及烟草生物标志物暴露情况。
随机、平行组8周研究,分为VLNC组(VLNC 1,n = 53)或NNC组(NNC,n = 27),可使用非香烟类燃烧及非燃烧烟草/尼古丁产品;或VLNC组(VLNC2,n = 56),仅可使用非燃烧产品。
美国明尼苏达州的诊所。
对戒烟不感兴趣的吸烟者,平均年龄[±标准差(SD)]为44(±14)岁,每天吸烟16(±7)支;51%为女性,72%为白人。
在实验期间,所采取的测量指标包括:替代产品的使用频率、燃烧烟草的使用量及戒断情况、烟草暴露生物标志物。
与NNC组相比,两种VLNC组条件下非燃烧替代烟草/尼古丁产品的使用率均更高[率比(RR)= 2.18,95%置信区间(CI)= 1.94,2.46;RR = 1.64,95% CI = 1.46,1.85],且VLNC1组与VLNC2组相比(RR = 1.33,95% CI = 1.23,1.44);与NNC组相比,主要在VLNC2组条件下暴露生物标志物减少(P < 0.05)。几乎在所有访视中,燃烧产品的吸烟量均减少(P≤0.02),与NNC组相比,两种VLNC组条件下的戒断率均更高(VLNC1组与NNC组:RR = 9.96,95% CI = 5.01,19.81;VLNC2组与NNC组:RR = 11.23,95% CI = 5.74,21.97)。
在8周期间提供并指导使用尼古丁含量降低的香烟,与继续使用正常尼古丁香烟相比,导致更多地使用替代烟草/尼古丁产品,且吸烟率降低。